Myopathy 359.9
alcoholic 359.4
amyloid 277.39 [359.6]
benign, congenital 359.0
central core 359.0
centronuclear 359.0
congenital (benign) 359.0
critical illness 359.81
distal 359.1
due to drugs 359.4
endocrine 259.9 [359.5]
specified type NEC 259.8 [359.5]
extraocular muscles 376.82
facioscapulohumeral 359.1
in
Addison's disease 255.41 [359.5]
amyloidosis 277.39 [359.6]
cretinism 243 [359.5]
Cushing's syndrome 255.0 [359.5]
disseminated lupus erythematosus 710.0 [359.6]
giant cell arteritis 446.5 [359.6]
hyperadrenocorticism NEC 255.3 [359.5]
hyperparathyroidism 252.01 [359.5]
hypopituitarism 253.2 [359.5]
hypothyroidism (see also Hypothyroidism) 244.9 [359.5]
malignant neoplasm NEC (M8000/3) 199.1 [359.6]
myxedema (see also Myxedema) 244.9 [359.5]
polyarteritis nodosa 446.0 [359.6]
rheumatoid arthritis 714.0 [359.6]
sarcoidosis 135 [359.6]
scleroderma 710.1 [359.6]
Sjögren's disease 710.2 [359.6]
thyrotoxicosis (see also Thyrotoxicosis) 242.9 [359.5]
inflammatory 359.79
immune NEC 359.79
specified NEC 359.79
intensive care (ICU) 359.81
limb-girdle 359.1
myotubular 359.0
nemaline 359.0
necrotizing, acute 359.81
ocular 359.1
oculopharyngeal 359.1
of critical illness 359.81
primary 359.89
progressive NEC 359.89
proximal myotonic (PROMM) 359.21
quadriplegic, acute 359.81
rod body 359.0
scapulohumeral 359.1
specified type NEC 359.89
toxic 359.4

Home